From: Outcome of recurrent and metastatic small cell carcinoma of the bladder
Localisation of recurrence | Histology (Mixed or pure SmCC) | Treatment | Response | Survival (months) | Death |
---|---|---|---|---|---|
Rectum | mixed | Surgery + CT (3EP) + RT | Progressive | 7.1 | yes |
Neo-bladder | Mixed | CT (6MVAC) | PR < 50% | 10 | yes |
RP | Pure | CT (4EP) | Stable | 5.5 | yes |
RP | Mixed | RT (Y 45 Gy) + chemotherapy (4G) | Stable | 7.7 | yes |
RP | Mixed | CT (4GC) + RT (Y 45 Gy) | CR | 28.8 | yes |
CNS | Pure | CT (1 EP + 1 MTX intrathecal) | - | 0.4 | yes |
CNS | Pure | RT (30 Gy) | Progressive | 3.7 | yes |
Liver and RP | Mixed | CT (1GC) | Progressive | 0.7 | yes |
Liver and RP | Mixed | CT (4G) | Progressive | 3.1 | yes |
Liver and Bone | Pure | CT (6EP) | PR > 50% | 20.3 | no |
Lung and RP | Mixed | CT (6EP) | PR > 50% | 14.7 | no |
Lung | Mixed | CT (6EP in first line and 6GC in second line) | PR > 50% (in first line) | 26.3 | yes |